BRPI0820993A2 - método e composição para tratar uma condição mediada por alfa adrenoceptor - Google Patents
método e composição para tratar uma condição mediada por alfa adrenoceptorInfo
- Publication number
- BRPI0820993A2 BRPI0820993A2 BRPI0820993A BRPI0820993A BRPI0820993A2 BR PI0820993 A2 BRPI0820993 A2 BR PI0820993A2 BR PI0820993 A BRPI0820993 A BR PI0820993A BR PI0820993 A BRPI0820993 A BR PI0820993A BR PI0820993 A2 BRPI0820993 A2 BR PI0820993A2
- Authority
- BR
- Brazil
- Prior art keywords
- treating
- composition
- mediated condition
- alpha adrenoceptor
- adrenoceptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1337507P | 2007-12-13 | 2007-12-13 | |
| PCT/US2008/086733 WO2009076663A1 (en) | 2007-12-13 | 2008-12-13 | Method and composition for treating an alpha adrenoceptor-mediated condition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0820993A2 true BRPI0820993A2 (pt) | 2017-05-09 |
Family
ID=40289315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0820993A BRPI0820993A2 (pt) | 2007-12-13 | 2008-12-13 | método e composição para tratar uma condição mediada por alfa adrenoceptor |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8729100B2 (pt) |
| EP (1) | EP2222301B1 (pt) |
| JP (1) | JP5729808B2 (pt) |
| AU (1) | AU2008334932B2 (pt) |
| BR (1) | BRPI0820993A2 (pt) |
| CA (1) | CA2709103C (pt) |
| ES (1) | ES2527515T3 (pt) |
| MX (1) | MX2010006520A (pt) |
| NZ (1) | NZ585922A (pt) |
| WO (1) | WO2009076663A1 (pt) |
| ZA (1) | ZA201004212B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2222300B1 (en) * | 2007-12-13 | 2014-06-11 | Vanda Pharmaceuticals Inc. | Method and composition for treating a serotonin receptor-mediated condition |
| MX2010006520A (es) | 2007-12-13 | 2010-11-30 | Vanda Pharmaceuticals Inc | Metodo y composicion para el tratamiento de una condicion mediada por alfa-adrenoceptor. |
| BR112012015084A2 (pt) | 2009-12-23 | 2017-03-07 | Lupin Ltd | composição farmacêutica de liberação lenta de iloperidone |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4772475A (en) | 1985-03-08 | 1988-09-20 | Yamanouchi Pharmaceutical Co., Ltd. | Controlled-release multiple units pharmaceutical formulation |
| US5364866A (en) | 1989-05-19 | 1994-11-15 | Hoechst-Roussel Pharmaceuticals, Inc. | Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics |
| US5776963A (en) | 1989-05-19 | 1998-07-07 | Hoechst Marion Roussel, Inc. | 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility |
| GB9611356D0 (en) * | 1996-05-31 | 1996-08-07 | Howard Alan N | Improvements in or relating to compositions containing Creatine, and other ergogenic compounds |
| US6312728B1 (en) | 1998-07-07 | 2001-11-06 | Cascade Development, Inc. | Sustained release pharmaceutical preparation |
| US5968554A (en) | 1998-07-07 | 1999-10-19 | Cascade Development, Inc. A Subsidiary Of Cardinal Health, Inc. | Sustained release pharmaceutical preparation |
| US6627223B2 (en) | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
| ATE518845T1 (de) * | 2001-08-31 | 2011-08-15 | Novartis Pharma Gmbh | Optische isomere eines iloperidon-metaboliten |
| US6500454B1 (en) | 2001-10-04 | 2002-12-31 | Eurand Pharmaceuticals Ltd. | Timed, sustained release systems for propranolol |
| WO2003037337A1 (en) | 2001-10-30 | 2003-05-08 | Novartis Ag | Depot formulations of iloperidone and a star polymer |
| ES2364037T3 (es) | 2001-12-10 | 2011-08-23 | Novartis Ag | Métodos de tratamiento de psicosis y esquizofrenia basados en polimorfismos del gen del cntf. |
| US6663888B2 (en) | 2001-12-14 | 2003-12-16 | Eurand Pharmaceuticals Ltd. | Pulsatile release histamine H2 antagonist dosage form |
| GB0216416D0 (en) | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
| DK1558582T3 (da) | 2003-07-22 | 2006-05-08 | Arena Pharm Inc | Diaryl og arylheteroarylureaderivater som modulatorer af aktiviteten af 5-HT2A-serotoninreceptoren anvendelige til profylakse eller behandling af forstyrrelser relateret dertil |
| ES2825949T3 (es) | 2004-09-30 | 2021-05-17 | Vanda Pharmaceuticals Inc | Métodos para administrar iloperidona |
| SA05260357B1 (ar) * | 2004-11-19 | 2008-09-08 | ارينا فارماسيتو تيكالز ، أنك | مشتقات 3_فينيل_بيرازول كمعدلات لمستقبل سيروتينين 5_ht2a مفيدة في علاج الاضطرابات المتعلقه به |
| DE102005016981A1 (de) * | 2005-04-13 | 2006-10-19 | Bayer Healthcare Ag | Kombination zur Therapie bei benigner Prostatahyperplasie |
| MX2010006520A (es) | 2007-12-13 | 2010-11-30 | Vanda Pharmaceuticals Inc | Metodo y composicion para el tratamiento de una condicion mediada por alfa-adrenoceptor. |
| EP2222300B1 (en) | 2007-12-13 | 2014-06-11 | Vanda Pharmaceuticals Inc. | Method and composition for treating a serotonin receptor-mediated condition |
-
2008
- 2008-12-13 MX MX2010006520A patent/MX2010006520A/es active IP Right Grant
- 2008-12-13 ES ES08859451.0T patent/ES2527515T3/es active Active
- 2008-12-13 WO PCT/US2008/086733 patent/WO2009076663A1/en active Application Filing
- 2008-12-13 EP EP08859451.0A patent/EP2222301B1/en active Active
- 2008-12-13 AU AU2008334932A patent/AU2008334932B2/en active Active
- 2008-12-13 NZ NZ585922A patent/NZ585922A/xx unknown
- 2008-12-13 BR BRPI0820993A patent/BRPI0820993A2/pt not_active Application Discontinuation
- 2008-12-13 CA CA2709103A patent/CA2709103C/en active Active
- 2008-12-13 JP JP2010538216A patent/JP5729808B2/ja active Active
- 2008-12-13 US US12/747,911 patent/US8729100B2/en active Active
-
2010
- 2010-06-14 ZA ZA2010/04212A patent/ZA201004212B/en unknown
-
2014
- 2014-03-05 US US14/197,318 patent/US10272075B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| NZ585922A (en) | 2012-10-26 |
| EP2222301B1 (en) | 2014-10-08 |
| ES2527515T3 (es) | 2015-01-26 |
| ZA201004212B (en) | 2012-11-28 |
| AU2008334932B2 (en) | 2014-05-22 |
| EP2222301A1 (en) | 2010-09-01 |
| MX2010006520A (es) | 2010-11-30 |
| US20100273809A1 (en) | 2010-10-28 |
| JP2011506481A (ja) | 2011-03-03 |
| CA2709103C (en) | 2017-01-17 |
| CA2709103A1 (en) | 2009-06-18 |
| US8729100B2 (en) | 2014-05-20 |
| WO2009076663A1 (en) | 2009-06-18 |
| US10272075B2 (en) | 2019-04-30 |
| AU2008334932A1 (en) | 2009-06-18 |
| US20140194459A1 (en) | 2014-07-10 |
| JP5729808B2 (ja) | 2015-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0807918A2 (pt) | composições e método para preservação de tecido | |
| BRPI0810806A2 (pt) | Método para tratar uma lesão cutânea em um indivíduo | |
| BRPI0908854A2 (pt) | composições e métodos para o tratamento de tumor de origem hematopoética | |
| BRPI0913129A2 (pt) | método para tratamento de hiperuricemia empregando um inibidor de sglt2 e composição contendo o mesmo | |
| BRPI0813725A2 (pt) | Métodos e composições para tratamento de doenças | |
| BRPI0815387A2 (pt) | composição farmacêutica, método para fazer uma composição farmacêutica e método de tratar uma condição | |
| BRPI0921321A2 (pt) | métodos para o tratamento de indwcções e tumores | |
| BRPI0822972A2 (pt) | "método e aparelho para redução de atrito" | |
| BRPI0922122A2 (pt) | composições e métodos para tratamento de doença celíaca. | |
| BRPI0920284A2 (pt) | composição e método | |
| BRPI0909164A2 (pt) | método e composições para o tratamento de câncer | |
| BRPI0919238A2 (pt) | métodos e composições para o tratamento de câncer | |
| BRPI0911757A2 (pt) | composiÇÕes e mÉtodos para tratar distérbios digestivos. | |
| BRPI0912830A2 (pt) | aparelho e método para aliviar obstrução de uma via aérea | |
| BRPI0918170A2 (pt) | método, e, composição endurecível | |
| BRPI0808024A2 (pt) | Método para desengomar uma composição de óleo, e, processo para desengomadura de óleo | |
| BRPI0811589A2 (pt) | Composição farmacêutica e método para tratar câncer | |
| BRPI1006145A2 (pt) | "composição e método para tratamento de diabetes". | |
| BRPI0921959A2 (pt) | métodos e composições para remoção de tatuagem | |
| BRPI0815881A2 (pt) | Composição de revestimento de poliuretano e método para tratar uma surpeficie envelhecida | |
| BRPI1011325A2 (pt) | composições e métodos para o tratamento de inflamação | |
| BRPI1007600A2 (pt) | composições e métodos para tratamento de doenças cardiovasculares | |
| BRPI0914023A2 (pt) | composição nutricional e método para fornecer uma nutrição | |
| BR112013011569A2 (pt) | elemento de guia e dispositivo para realização de uma perfuração óssea | |
| BRPI0911580A2 (pt) | composições para o tratamento de uma condição artrítica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal: appeal against refusal | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |